Fortis Healthcare Q4 loss at Rs37.52 crore
Fortis Healthcare reported a consolidated net loss of Rs37.52 crore for the fourth quarter , as against a net loss of Rs87.60 crore for the corresponding period of previous fiscal30-05-2017
30-05-2017
Outcome of Board Meeting
This is to inform you that the Board of Directors of the Company at its meeting held today, inter-alia, considered and approved the Audited Consolidated and Standalone Financial Results of the Company for the quarter and year ended on March 31, 2017. M/s. Deloitte Haskins & Sells LLP, the Statutory Auditors of the Company have issued Auditors Report with an unmodified opinion on the Financial Statements. The Board Meeting commenced at 1200 Noon and concluded at 1730 Hours.30-05-2017
Notice of Postal Ballot
Fortis Healthcare Ltd has submitted to BSE a Copy of the Notice of Postal Ballot.26-05-2017
Notice of Postal Ballot
Postal Ballot Notice - To increase the shareholding limit for Registered Foreign Institutional Investors (FIIs) from 24% upto an aggregate limit of 74% of the paid-up equity share capital of the Company26-05-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt Ltd26-05-2017
Updates
This is to inform that the Board of Directors have today, approved a proposal to enhance the ceiling limit on total holdings of FII/SEBI approved sub-accounts of FIIs, FPIs, QFIs, Non Resident Indians (NRIs) and Person of Indian Origin (PIO) under the Portfolio Investment Scheme upto 74% of the paid-up equity capital of the Company. The said increase is subject to the approval of the shareholders and such statutory/ regulatory approvals as may be necessary in this regard....25-05-2017
Board Meeting On May 30, 2017
Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday, May 30, 2017 to, inter-alia, consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2017. Further, the trading window of the Company for dealing in securities...22-05-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt Ltd19-05-2017
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL India Ltd19-05-2017